Skip to main content
Log in

Serum levels of antioxidants and age-related macular degeneration

  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

A number of reports have suggested that oxidative damage in the retina may contribute to the pathogenesis of Age-related macular degeneration (AMD). The present study was designed to investigate the hypothesis that serum levels of the antioxidants, Vitamin E and selenium are related to the pathogenesis of AMD. Fasting bloods were obtained from 80 patients with AMD and 86 controls. Assays for serum levels of Vitamin E, selenium, cholesterol and triglycerides were performed. Assessment of patients and controls was based upon eye examination, fundus photography and medical history. No significant difference was found in serum levels of Vitamin E between subjects and controls, however, there was a borderline association between AMD and both serum selenium levels and current smoking status. The results suggest that if oxidative damage is a factor in the pathogenesis of AMD, it is not reflected in serum levels of Vitamin E; further studies are required to clarify the possible relationship between serum selenium levels, smoking and AMD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Robison WG, Kuwabara T, Bieri JG. The roles of vitamin E and unsaturated fatty acids in the visual process. Retina 1982; 2: 263–81.

    Google Scholar 

  2. Dilley RA, McConnell DG. Alpha-tocopherol in the retinal outer segment of bovine eyes. J Memb Biol 1970; 2: 317–23.

    Google Scholar 

  3. Farnsworth CC, Dratz EA. Oxidative damage of retinal rod outer segment membranes and the role of vitamin E. Biochem Biophys Acta 1976; 443: 556–70.

    Google Scholar 

  4. Hunt DF, Organisciak DT, Wang HM, Wu RC. Alpha-tocopherol in the developing rat retina: a high pressure liquid chromatographic analysis. Curr Eye Res 1984; 3: 1281–88.

    Google Scholar 

  5. Organisciak DT, Breman ER, Wang HM, Feeney-Burns L. Vitamin E in human neural retina and retinal pigment epithelium: effect of age. Curr Eye Res 1987; 68: 1051–55.

    Google Scholar 

  6. Hayes KC. Retinal degeneration in monkeys induced by deficiencies of vitamin E or A. Invest Ophthalmol 1974; 13: 499–510.

    Google Scholar 

  7. Katz ML, Stone WL, Dratz EA. Fluorescent pigment accumulation in retinal pigment epithelium of antioxidant-deficient rats. Invest Ophthalmol Vis Sci 1978; 17: 1049–1058.

    Google Scholar 

  8. Katz ML, Parker KR, Handelman GJ et al. Effects of antioxidant nutrient deficiency on the retina and retinal pigment epithelium of albino rats: a light and electron microscopic study. Exp Eye Res 1982; 34: 339–69.

    Google Scholar 

  9. Robison WG Jr, Kuwabara T, Bieri JG. Vitamin deficiency and the retina: photoreceptor and pigment epithelial changes. Invest Ophthalmol Vis Sci. 1979; 18: 683–90.

    Google Scholar 

  10. Robison WG Jr, Kuwabara T, Bieri JG. Deficiencies of vitamin E and A in the rat, retinal damage and lipofuscin accumulation. Invest Ophthalmol Vis Sci 1980; 19: 1030–37.

    Google Scholar 

  11. Katz ML, Robison WG. Light and aging effects on vitamin E in the retina and retinal pigment epithelium. Vis Res 1987; 11: 1875–79.

    Google Scholar 

  12. Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol 1987; 31: 291–306.

    Google Scholar 

  13. Stone WL, Katz ML, Lurke M et al. Effects of dietary vitamin E and selenium on light damage to the rat retina. Photochem Photobiol. 1979; 29: 725–30.

    Google Scholar 

  14. Katz ML, Eldred GE. Failure of vitamin E to protect the retina against damage resulting from bright cyclic light exposure. Invest Ophthalmol Vis Sci 1989; 30: 29–36.

    Google Scholar 

  15. Blumenkranz MS, Russell SR, Robey MG, Kott-Blumenkranz R, Penneys N. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 1986; 96: 552–58.

    Google Scholar 

  16. Salonen JT, Salonen R, Lappetelainer R, Maenpaa PH, Alfthan G, Puska P. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br Med J 1985; 290: 417–20.

    CAS  Google Scholar 

  17. Kok FJ, de Bruijn AM, Vermeeren R, Hufman A, van Laar A et al. Serum selenium, vitamin antioxidants and cardiovascular mortality: a 9-year followup study in the Netherlands. Am J Clin Nutr 1987; 45: 462–68.

    Google Scholar 

  18. Menkes MS, Comstock GW, Vuilleumier JP, Helsing KJ, Rider AA, Brookmeyer R. Serum beta-carotene, vitamins A and E, selenium and the risk of lung cancer. N Engl J Med 1986; 315: 1250–54.

    Google Scholar 

  19. Tappel AL. Vitamin E as the biological lipid antioxidant. Vitam Horm 1962; 20: 493–510.

    Google Scholar 

  20. Molenaar I, Hulstaert CE, Hadonk MJ, in Machlin LJ (ed), Vitamin E: a comprehensive treatise. New York: Marcel Dekker, 1980: 372–89.

    Google Scholar 

  21. McKay PB, King MM, in Machlin LJ (ed), Vitamin E: a comprehensive treatise. New York: Marcel Dekker, 1980: 289–317.

    Google Scholar 

  22. Combs GF, Combs SB. The nutritional biochemistry of selenium. In: Darby WJ, Broquist HP, Olson RE, (eds), Annual Review of Nutriton, Vol 4, Palo Alto: Annual Review Inc, 1984: 257.

    Google Scholar 

  23. Tappel AL. Vitamin E and selenium protection from in vivo lipid peroxidation. In: Levander Oa, Cheng L (eds), Micronutrient interactions: vitamins, minerals, and hazardous elements. New York: New York Academy of Sciences, 1980: 18–31.

    Google Scholar 

  24. Penfold PL, Provis JM, Furby JH, Gatenby PA, Billson FA. Autoantibodies to retinal astrocytes associated with age-related macular degeneration. Graefe's Arch Clin Exp Ophthalmol 1990; 228: 270–74.

    Google Scholar 

  25. Bressler NM, Bressler SB, West SK, Fine SL, Taylor HR. The grading and prevalence of macular degeneration in Chesapeake Bay Watermen. Arch Ophthalmol 1989; 107: 847–52.

    Google Scholar 

  26. Jacques PF, Chylack LT, McGandy RB, Hartz SC. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol 1988; 106: 337–40.

    Google Scholar 

  27. Rubinstein HM, Deitz AA, Srinivasan R. Relationships of vitamin E and serum lipids. Clin Chim Acta 1969; 23: 1–6.

    Google Scholar 

  28. Desai ID, Lee M. Plasma vitamin E and cholesterol relationship in Western Canadian Indians. Am J Clin Nutr 1974; 27: 334–38.

    Google Scholar 

  29. Leibowitz HM, Krueger DE, Maunder LR et al. The Framingham Eye Study Monograph. Surv Ophthalmol 1980; 24 (suppl): 335–610.

    Google Scholar 

  30. Kahn HA, Leibowitz HM, Ganley JP et al. The Framingham Eye Study, II: Association of opthalmic pathology with single variables previously mentioned in the Framingham Heart Study. AM J Epidemiol 1977; 106: 33–41.

    Google Scholar 

  31. Vinding T. Pigmentation of the eye and hair in relation to age-related macular degeneration: an epidemiological study of 1000 aged individuals. Acta Ophthalmol 1990; 68: 53–58.

    Google Scholar 

  32. Sperduto RD, Hiller R. Systemic hypertension and age-related maculopathy in the Framingham study. Arch Ophthalmol 1986; 104: 216–19.

    Google Scholar 

  33. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MOM. Factors associated with age-related macular degeneration. Am J Epidemiol 1988; 128: 700–10.

    Google Scholar 

  34. Hyman LG, Lilienfeld AM, Ferris FL, Fine SL. Senile macular degeneration: a case-control study. Am J Epidemiol 1983; 118: 213–27.

    CAS  PubMed  Google Scholar 

  35. West SK, Rosenthal FS, Bressler NM et al. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol 1989; 107: 875–79.

    Google Scholar 

  36. Behrens WA, Thompson JN, Madére R. Distribution of alpha-tocopherol in human plasma lipoproteins. AM J Clin Nutr 1982; 35: 691–96.

    Google Scholar 

  37. Traber MG, Kayden HJ. Vitamin E is delivered to cells via the high affinity receptor for low density lipoprotein. Am J Clin Nutr 1984; 40: 747–51.

    Google Scholar 

  38. Liles MR, Newsome DA, Oliver PD. Antioxidant enzymes in the aging human retinal pigment epithelium. Arch Ophthalmol 1991; 109: 1285–88.

    CAS  PubMed  Google Scholar 

  39. Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration: The involvement of immunocompetent cells. Graefe's Arch Clin Exp Ophthalmol 1985; 223: 69–76.

    Google Scholar 

  40. Penfold PL, Killingsworth MC, Sarks SH. Senile macular dengeration: The involvement of giant cells in atrophy of the retinal pigment epithelium. Invest Ophthalmol Vis Sci 1986; 27: 364–71.

    Google Scholar 

  41. Penfold PL, Provis JM, Billson FA. Age-related macular degeneration: Ultrastructural studies of the relationship of leucocytes to angiogenesis. Graefe's Arch Clin Exp Ophthalmol 1987; 225: 70–76.

    Google Scholar 

  42. Clark RA, Nauseef WM. Phagocyte oxidants and protective mechanisms. In: Chow CK (ed), Cellular antioxidant denfense mechanisms, vol 2. Florida: CRC Press, 1988 Chap 23: 149–57.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsang, N.C.K., Penfold, P.L., Snitch, P.J. et al. Serum levels of antioxidants and age-related macular degeneration. Doc Ophthalmol 81, 387–400 (1992). https://doi.org/10.1007/BF00169100

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00169100

Key words

Navigation